Global Rat Model Market Size 2024, Forecast To 2033
6 Mar, 2024
The rat model market has experienced robust growth in recent years, ascending from $1.56 billion in 2023 to $1.69 billion in 2024, registering a compound annual growth rate (CAGR) of 8.3%. The surge in the historical period can be attributed to the escalating demand for preclinical research, increased government funding, heightened research demands, initiatives in drug development, and the growing prevalence of chronic diseases. Looking ahead to the future, the rat model market is poised for strong growth, anticipating a market size of $2.34 billion in 2028, with a CAGR of 8.5%. Factors contributing to this growth in the forecast period include the expanding applications in personalized medicine, a growing demand for animal models in drug discovery, an increased focus on disease prevention, the expansion of the biopharmaceutical industry, innovations in imaging techniques, and sustained government and private funding. Prominent trends include global collaborations in research, technological advancements in imaging, the integration of omics technologies, advancements in genome editing techniques, the growing importance of rat models in disease research, and the rise of personalized medicine with customized rat models.
Global Rat Model Market Key Driver
The projected surge in chronic diseases is set to bolster the growth of the rat model market. Chronic diseases, characterized by lasting a year or more, impairing daily activities, and requiring continuous medical attention, underscore the importance of rat models in researching pathogenesis, immune responses, and treatment strategies for such conditions. As per a report from the National Institutes of Health (NIH) in 2023, the United States is expected to witness a 99.5% increase in the number of individuals aged 50 and older with at least one chronic illness, rising from 71.522 million in 2020 to 142.66 million in 2050. Moreover, the prevalence of multimorbidity is forecasted to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the rising incidence of chronic diseases serves as a significant driver for the rat model market, with market sizes of 2023, 2024, and 2028 playing a pivotal role in this trajectory.
Get A Free Sample Of The Global Rat Model Market ReportGlobal Rat Model Market Segments
The rat model market covered in this report is segmented –
1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned
2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing, Quarantine Depending, Other Services
3) By Technology: Nuclear Transferase, Microinjection, Embryonic Stem Cell, Other Technologies
4) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications
By Geography:The regions covered in the rat model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the rat model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Rat Model Industry Players
Genoway S.A., Biomere, Transposagen Biopharmaceuticals Inc., Horizon Discovery Group PLC, Transviragen Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Envigo Ltd., Laboratory Corporation of America Holdings, Janvier Labs, Harlan Laboratories Inc., Sage Path Labs, Applied StemCell Inc., Regenera Pharma Ltd., Cyagen Biosciences Inc., Ozgene Pty Ltd, Yecuris Corporation, Hera BioLabs Inc., Beijing Biocytogen Co. Ltd., Ingenious Targeting Laboratory, InVivos Pte Ltd., Kymab Limited, Mirimus Inc., Pharmaron Beijing Co. Ltd., PolyGene AG, Shanghai Model Organisms Center Inc., Sino Biological Inc., Synthego Corporation, Transgenic Inc., ViGene Biosciences Inc., Viva Biotech Holdings, WuXi AppTec Co. Ltd.
Get The Full Global Rat Model Market Report
Rat Model Market Overview
The rat model refers to a process that uses rat functional genes, cells, tissues, and organs. These mouse models are employed to simulate both pathological and healthy conditions of the human immune system. The use of humanized rat models is crucial for preclinical research since they may be used to simulate human disease states, evaluate the effectiveness of compounds, and examine how they affect human proteins.
Rat Model Global Market Report 2023 provides data on the global rat model market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The rat model market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.